Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Kropacheva ES"'
Autor:
Krivosheeva EN; Chazov National Medical Research Center of Cardiology., Komarov AL; Chazov National Medical Research Center of Cardiology., Panchenko EP; Chazov National Medical Research Center of Cardiology., Khakimova MB; Chazov National Medical Research Center of Cardiology., Kropacheva ES; Chazov National Medical Research Center of Cardiology., Pogorelova OA; Chazov National Medical Research Center of Cardiology., Balakhonova TV; Chazov National Medical Research Center of Cardiology., Titaeva EV; Chazov National Medical Research Center of Cardiology., Dobrovolsky AB; Chazov National Medical Research Center of Cardiology., Galyautdinov DM; Chazov National Medical Research Center of Cardiology., Vlasova EE; Chazov National Medical Research Center of Cardiology.
Publikováno v:
Terapevticheskii arkhiv [Ter Arkh] 2024 Jul 30; Vol. 96 (7), pp. 683-689. Date of Electronic Publication: 2024 Jul 30.
Autor:
A N Rogoza, Marina V. Kostiukevich, Panchenko Ep, Iuliia A. Iuricheva, Alexander Litvin, E. Zheleznova, I E Chazova, E M Elfimova, Madina D. Utsumueva, Sergei P. Golitsyn, Lada Iu. Laiovich, Juliya V. Zhernakova, Kropacheva Es, Nikolai Iu. Mironov
Publikováno v:
Системные гипертензии, Vol 18, Iss 3, Pp 105-128 (2021)
Arterial hypertension (AH) is a leading risk factor for cardiovascular disease as well as it is the most common, independent and potentially reversible risk factor for atrial fibrillation (AF). AH contributes to the occurrence and maintenance of AF d
Autor:
Kropacheva ES; Chazov National Medical Research Center of Cardiology., Zemlyanskaya OA; Chazov National Medical Research Center of Cardiology., Panchenko EP; Chazov National Medical Research Center of Cardiology.
Publikováno v:
Kardiologiia [Kardiologiia] 2023 Nov 08; Vol. 63 (10), pp. 55-62. Date of Electronic Publication: 2023 Nov 08.
Publikováno v:
Терапевтический архив, Vol 92, Iss 9, Pp 15-23 (2020)
To analyze the frequency of resumption of anticoagulant therapy (ACT) after major and clinically significant bleeding among AF patients who received oral anticoagulants and were observed in the Department of clinical problems of atherothrombosis from
Autor:
N P Mitkovskaya, A O Konradi, Komarov Al, E I Tarlovskaya, Ye V Shlyakhto, V A Snezhitskiy, S V Malchikova, A I Chesnikova, L V Kolotsey, M M Petrova, A B Sugraliyev, V V Skibitsky, A G Arutyunov, N. A. Koziolova, Ya A Orlova, Tereshchenko Sn, Kropacheva Es, G P Arutyunov, I. V. Fomin, Yu N Belenkov, Panchenko Ep, I. S. Yavelov, Ardashev Av, I I Shaposhnik, N Yu Grigorieva, G A Dzhunusbekova, S G Kanorskii, A P Rebrov, Hamayak Sisakian, E G Zhelyakov, O. M. Drapkina
Publikováno v:
Kardiologiia. 60:4-14
This article discusses relevant aspects in the treatment of patients with COVID-19. Up-to-date information about principles for administration of statins, antithrombotics, and antiarrhythmics is presented. The authors addressed in detail specific fea
Publikováno v:
Терапевтический архив, Vol 91, Iss 9, Pp 38-46 (2019)
To evaluate efficacy and safety of reduced dose of direct oral anticoagulants (DOACs) as part of triple antithrombotic therapy in AF patients, undergoing elective percutaneous coronary intervention (PCI), and to identify factors, associated with this
Autor:
A. B. Dobrovolsky, Elizaveta Panchenko, Anatoly Samko, Elena N. Krivosheeva, Kropacheva Es, Titaeva Ev
Publikováno v:
Circulation. 142
Introduction: Patients (pts) with AF, undergoing elective PCI, receiving multicomponent antithrombotic therapy (MAT) have high risk of stroke/systemic embolism and coronary events. There is no biochemical markers associated with negative prognosis in
Autor:
A. B. Dobrovolsky, Panchenko Ep, Kropacheva Es, V M Mironov, E N Krivosheeva, Titaeva Ev, A N Samko
Publikováno v:
Kardiologiia. 60(8)
Aim Searching for clinical, angiographic, and biochemical predictors of cardiovascular complications (CVC) and hemorrhagic complications in patients with atrial fibrillation (AF) receiving a multicomponent antithrombotic therapy (MAT) for an elective
Autor:
Kropacheva ES; Chazov National Medical Research Center of Cardiology., Zemlyanskaya OA; Chazov National Medical Research Center of Cardiology., Krivosheeva EN; Chazov National Medical Research Center of Cardiology., Panchenko EP; Chazov National Medical Research Center of Cardiology.
Publikováno v:
Terapevticheskii arkhiv [Ter Arkh] 2023 Jan 16; Vol. 94 (12), pp. 1374-1380. Date of Electronic Publication: 2023 Jan 16.
[Renal function in patients receiving long-term warfarin therapy: A five-year prospective follow-up]
Publikováno v:
Терапевтический архив, Vol 89, Iss 9, Pp 78-86 (2017)
To investigate the prognostic value of renal function and to estimate glomerular filtration rate (GFR) changes during a 5-year follow-up of patients receiving warfarin therapy.200 patients (124 men, 76 women) mainly from a group at high risk for thro